Studies on improving semen quality and increasing pregnancy chances through the in vitro addition of L-carnitine and coenzyme Q10 to semen in patients with asthenozoospermia

Background: At present, L-carnitine (LC) and coenzyme Q10 (CoQ10), as used clinically to treat male infertility caused by asthenozoospermia (ASZ) is still mainly administered orally, but some patients with ASZ still show no significant improvement in sperm motility and spouse pregnancy rate. Prodom is a device used to assist reproduction, which is temporarily fitted onto the penis to facilitate conception by helping the wife inject a certain drug into the vagina. This study used Prodom-assisted LC/CoQ10 in the treatment of patients with ASZ and evaluated the effect of this method on sperm motility and clinical pregnancy, with the goal of finding a comfortable, low-cost, effective method. Results: During the trial period, 232 cases completed the trial, while 25 cases did not. During in vitro testing, the progressive sperm motility in the LC group, CoQ10 group, LC combined with CoQ10 group, and the semen blank control group was 24.3 +/- 4.6% and 38.1 +/- 5.1%, 23.0 +/- 4.8% and 36.9 +/- 4.4%, 28.4 +/- 5.0% and 43.8 +/- 5.4%, 19.7 +/- 4.4% and 26.0 +/- 4.9%, respectively. There were statistically significant differences in progressive sperm motility among the groups (all P values <0.05). The pregnancy rates of the Prodom-assisted LC treatment group, Prodom-assisted CoQ10 treatment group, Prodom-assisted LC combined with CoQ10 treatment group, and oral LC combined with CoQ10 treatment group in the clinical treatment stage were 38.2, 35.4, 57.1, and 30.3%, respectively; the time to conception was 6.1 +/- 1.8, 6.2 +/- 1.8, 3.4 +/- 0.9, and 7.9 +/- 2.0, months respectively; and the treatment costs were $2350 +/- 457, $2455 +/- 434, $1348 +/- 411, and $2684 +/- 334, respectively. The differences in pregnancy rate, time to conception, and treatment costs among the groups were statistically significant (all P values <0.05). Conclusions: The supplementation of in vitro semen with LC/CoQ10 can improve sperm motility. LC/CoQ10 injected into the spouse's vagina with the assistance of a Prodom can increase the pregnancy rate, shorten the time to conception, and reduce the cost of treatment in patients with ASZ.